Szabo M D, Crosby G
Anaesthesia Service, Massachusetts General Hospital, Boston 02114.
Stroke. 1988 Jun;19(6):747-9. doi: 10.1161/01.str.19.6.747.
The purpose of our study was to investigate the effect of hypermagnesemia on spinal metabolic rate. The 2-[14C]deoxyglucose technique was used to measure regional glucose utilization in the lumbar spinal cord of paralyzed, mechanically ventilated rats receiving 70% nitrous oxide and an intravenous infusion of either saline (n = 5) or magnesium sulfate (n = 5). Plasma magnesium concentrations were 6.75 +/- 0.5 and 0.9 +/- 0.5 mM (p less than 0.01) in hypermagnesemic and control rats, respectively. Hypermagnesemic rats were hypotensive (88 +/- 1 vs. 130 +/- 4 mm Hg, p less than 0.01) but blood pressure remained within the autoregulatory range. Glucose utilization was reduced 26-45% in spinal gray matter and 53-63% in spinal white matter during hypermagnesemia. We conclude that magnesium is a potent spinal metabolic depressant and that this action, which is unusually prominent in spinal white matter, is a plausible explanation for the recently reported beneficial effect of magnesium therapy during spinal cord ischemia.
我们研究的目的是探讨高镁血症对脊髓代谢率的影响。采用2-[¹⁴C]脱氧葡萄糖技术,测量接受70%氧化亚氮并静脉输注生理盐水(n = 5)或硫酸镁(n = 5)的瘫痪、机械通气大鼠腰段脊髓的局部葡萄糖利用率。高镁血症大鼠和对照大鼠的血浆镁浓度分别为6.75±0.5和0.9±0.5 mM(p<0.01)。高镁血症大鼠血压降低(88±1对130±4 mmHg,p<0.01),但血压仍在自动调节范围内。高镁血症期间,脊髓灰质葡萄糖利用率降低26 - 45%,脊髓白质降低53 - 63%。我们得出结论,镁是一种强效的脊髓代谢抑制剂,这种作用在脊髓白质中异常突出,这可能是最近报道的镁治疗脊髓缺血有益效果的一个合理原因。